These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3883985)

  • 1. Human serum amyloid P component, a circulating lectin with specificity for the cyclic 4,6-pyruvate acetal of galactose. Interactions with various bacteria.
    Hind CR; Collins PM; Baltz ML; Pepys MB
    Biochem J; 1985 Jan; 225(1):107-11. PubMed ID: 3883985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding specificity of serum amyloid P component for the pyruvate acetal of galactose.
    Hind CR; Collins PM; Renn D; Cook RB; Caspi D; Baltz ML; Pepys MB
    J Exp Med; 1984 Apr; 159(4):1058-69. PubMed ID: 6707579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium-dependent aggregation of human serum amyloid P component. Inhibition by the cyclic 4,6-pyruvate acetal of galactose.
    Hind CR; Collins PM; Pepys MB
    Biochim Biophys Acta; 1984 Nov; 802(1):148-50. PubMed ID: 6435685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that serum amyloid P component binds to mannose-terminated sequences of polysaccharides and glycoproteins.
    Kubak BM; Potempa LA; Anderson B; Mahklouf S; Venegas M; Gewurz H; Gewurz AT
    Mol Immunol; 1988 Sep; 25(9):851-8. PubMed ID: 3211159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structures of crystalline complexes of human serum amyloid P component with its carbohydrate ligand, the cyclic pyruvate acetal of galactose.
    Thompson D; Pepys MB; Tickle I; Wood S
    J Mol Biol; 2002 Jul; 320(5):1081-6. PubMed ID: 12126626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific chemical dissociation of fibrillar and non-fibrillar components of amyloid deposits.
    Hind CR; Collins PM; Caspi D; Baltz ML; Pepys MB
    Lancet; 1984 Aug; 2(8399):376-8. PubMed ID: 6147456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentameric and decameric structures in solution of serum amyloid P component by X-ray and neutron scattering and molecular modelling analyses.
    Ashton AW; Boehm MK; Gallimore JR; Pepys MB; Perkins SJ
    J Mol Biol; 1997 Sep; 272(3):408-22. PubMed ID: 9325100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen.
    Noursadeghi M; Bickerstaff MC; Gallimore JR; Herbert J; Cohen J; Pepys MB
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14584-9. PubMed ID: 11121061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ayu C-reactive protein/serum amyloid P agglutinates bacteria and inhibits complement-mediated opsonophagocytosis by monocytes/macrophages.
    Shi YH; Chen K; Ma WJ; Chen J
    Fish Shellfish Immunol; 2018 May; 76():58-67. PubMed ID: 29481847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular chaperone properties of serum amyloid P component.
    Coker AR; Purvis A; Baker D; Pepys MB; Wood SP
    FEBS Lett; 2000 May; 473(2):199-202. PubMed ID: 10812074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I; Cars O
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value.
    Jager PL; Hazenberg BP; Franssen EJ; Limburg PC; van Rijswijk MH; Piers DA
    J Nucl Med; 1998 Apr; 39(4):699-706. PubMed ID: 9544684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human serum amyloid P component is a single uncomplexed pentamer in whole serum.
    Hutchinson WL; Hohenester E; Pepys MB
    Mol Med; 2000 Jun; 6(6):482-93. PubMed ID: 10972085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotype-associated lectin-binding profiles of normal and transformed blood cells: a comparative analysis of mannose- and galactose-binding lectins from plants and human serum/placenta.
    Mann KK; André S; Gabius HJ; Sharp JG
    Eur J Cell Biol; 1994 Oct; 65(1):145-51. PubMed ID: 7889985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum amyloid P aids complement-mediated immunity to Streptococcus pneumoniae.
    Yuste J; Botto M; Bottoms SE; Brown JS
    PLoS Pathog; 2007 Sep; 3(9):1208-19. PubMed ID: 17845072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of guinea-pig serum amyloid P component.
    Maudsley S; Hind CR; Munn EA; Buttress N; Pepys MB
    Immunology; 1986 Oct; 59(2):317-22. PubMed ID: 3770806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza virus infection is not affected by serum amyloid P component.
    Herbert J; Hutchinson WL; Carr J; Ives J; Jakob-Roetne R; Yamamura K; Suzuki M; Pepys MB
    Mol Med; 2002 Jan; 8(1):9-15. PubMed ID: 11984001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of the in vivo synthesis and catabolism of serum amyloid P component (SAP) in the mouse.
    Baltz ML; Dyck RF; Pepys MB
    Clin Exp Immunol; 1985 Jan; 59(1):235-42. PubMed ID: 3882285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of serum amyloid P-component (SAP) by amyloid fibrils.
    Pepys MB; Dyck RF; de Beer FC; Skinner M; Cohen AS
    Clin Exp Immunol; 1979 Nov; 38(2):284-93. PubMed ID: 118839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A C-type lectin (AiCTL-3) from bay scallop Argopecten irradians with mannose/galactose binding ability to bind various bacteria.
    Huang M; Song X; Zhao J; Mu C; Wang L; Zhang H; Zhou Z; Liu X; Song L
    Gene; 2013 Nov; 531(1):31-8. PubMed ID: 24008017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.